-
Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL
-
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA $16.58)
- $16.58 Cap: $19.01B
- View TEVA Profile
- View Questions on TEVA
-
Dr. Reddy's Laboratories Ltd (RDY $14.60)
- $14.60 P/E (TTM): 18.25X Cap: $12.18B
- View RDY Profile
- View Questions on RDY
-
Taro Pharmaceutical Industries Ltd. (TARO)
- P/E (TTM): 30.05X Cap: $1.61B
- View TARO Profile
- View Questions on TARO
Q: I am interested in buying a generic drug maker at this time. Which would you recommend ( TEVA or RDY). Would appreciate your recommendation if you don’t like these two.
Thanks
Thanks
-
Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL
Q: Hi Peter
can you revisit this company . Is it a buy at this point ?
can you revisit this company . Is it a buy at this point ?
-
Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL
Q: Myl
Hi Peter
Can you revisit Mylan for me . Do you still consider it a hold?
Hi Peter
Can you revisit Mylan for me . Do you still consider it a hold?
Insiders
Share Information
SEC Filings
News and Media